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signiﬁcant correlation has been observed between radiological damage
index and COMP levels, with a Pearson correlation index of 0.45 (95%CI:
0.32−0.64, p = 0.018).
Conclusions: We observed increased serum COMP levels in patients
with symptomatic radiological hand OA. Higher serum COMP levels
seems to correlate to more aggressive and severe disease, in terms of
pain (VAS values) and radiologic damage (Kellgren and Lawrence index).
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Purpose: It is socially required to establish the correlation of some spe-
ciﬁc biomarkers and the clinical stage of osteoarthritis (OA) or spondylosis
(SP). The aim of this study is to evaluate the usefulness of some serum
or urine biomarkers in OA or SP in the large population cohort study of
Japan.
Methods: Eight hundred and sixty four peoples (319 males and 544 fe-
males) over ﬁfty-year-old at the area of Hidakagawa-cho (Wakayama
prefecture) and Taichi-cho (Same) were the target of this study. Radio-
logical grade were estimated with Kellgren and Lawrence (K-L) grade.
Serum levels of cartilage oligomeric matrix protein (COMP), urinary
levels of CTX-I and CTX-II were measured and analysed to evaluate
the correlation of knee OA or SP.
Results: Prevalence of knee OA was 56.3% and lumbar SP was 62.6%.
Clinical stage of knee OA was that 79 in grade 0, 279 in grade 1, 359 in
grade 2, 97 in grade 3, 50 in grade 4. Clinical stage of SP was that 39 in
grade 0, 282 in grade 1, 275 in grade 2, 166 in grade 3, 102 in grade 4.
Serum levels of COMP and urine levels of CTX-II were both positively
correlated with the clinical stage of knee OA or lumbar SP (p< 0.0001)
in the analysis of covariance (ANCOVA). There was no correlation in
urinary levels of CTX-I and the radiological severity of knee OA or lumbar
SP. There was no correlation among COMP, CTX-I or CTX-II.
Conclusions: Serum levels of COMP and urinary levels of CTX-II were
usuful to evaluate the clinical stage of knee OA or lumbar SP. Biomarkers
in serum or urine were easy to collect and simple to estimate the clinical
evaluation of OA or SP.
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Purpose: Recent animal studies have suggested that Dkk-1, a secreted
inhibitor of Wnt signaling pathway, could play an important role in medi-
ating the alterations of joint tissue turnover associated with rheumatoid
arthritis (RA) and osteoarthritis (OA), but the clinical relevance of these
ﬁndings remain unclear. The aim of this study was to analyze the
associations between circulating Dkk-1 and cartilage and synovial tissue
turnover in patients with RA and knee OA.
Methods: We measured circulating Dkk-1 by a new sensitive two
site ELISA using antibodies raised against synthetic sequences of hu-
man Dkk-1 in 55 patients with active RA (65% women mean age:
55.4±14.1 yr, median disease duration 11 yr), 85 patients with painful
knee OA (74% women; mean age: 62.8±7.7 yr; radiological Kellgren
Lawrence score II-III, median disease duration: 41.5 months) and 93
healthy controls. Cartilage tissue degradation was evaluated by the
measurement of circulating levels of the type II collagen helical fragment
(Helix-II) and the type II collagenase neoepitope Col2:3/4Clongmono (C2C).
Synovial tissue metabolism was assessed by circulating levels of the
nitrosylated form of type III collagen N-telopeptide (IIINys).
Results: Compared to healthy sex and age matched controls, circulating
Dkk-1 levels were on average 83% higher (p< 0.0001) in patients with
RA, but 37% (p< 0.0001) lower in subjects with knee OA. In patients with
RA, Dkk-1 were positively associated with Helix-II (r = 0.48, p = 0.0018)
and IIINys (r = 0.28, p = 0.04) levels. Conversely, Dkk-1 levels negatively
correlated with C2C (r = −0.23, p = 0.035) in patients with knee OA.
Conclusions: Higher circulating Dkk-1 is associated with increased car-
tilage degradation and synovial tissue turnover in RA, but lower cartilage
destruction in patients with knee OA. These clinical data support the role
of Dkk-1 in joint damage in both RA and OA, with possible divergent
effects.
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Purpose: To examine the relationship between baseline angiogenic
biomarkers and disease activity in knee OA and to determine whether
treatment with an autologous Preparation Rich in Growth Factors (PRGF)
obtained from the patient’s own blood modulates speciﬁc angiogenic
biomarkers in synovial ﬂuid.
Methods: We performed a prospective longitudinal study comprising
a cohort of 81 symptomatic idiopathic or secondary knee OA patients
presenting with joint effusion. Patients were treated with a series of
three weekly intra-articular injections of autologous PRGF, which is
leukocyte-free plasma that is moderately enriched in platelets (2−3 fold
the levels found in peripheral blood). Synovial ﬂuid (SF) was aspirated
as part of the therapeutic procedure. ELISAs were used to determine
the levels of VEGF-A, HGF, and TGF-b1 in synovial ﬂuid before and
during the treatment. Response to PRGF treatment was deﬁned as a
reduction greater than 20% from baseline to week ﬁve post-treatment in
WOMAC sub-scales for pain, rigidity, and function. Spearman correlations
were computed to determine the relationship between baseline levels of
VEGF-A, HGF, and TGF-b1 and clinical variables including age, BMI,
Ahlba¨ck grade, and baseline WOMAC sub-scales. Pearson correlations
were also used to examine relationships between baseline biomarkers
and clinical variables. Improvement percentages for each of the WOMAC
sub-scales were analysed at 5 weeks post-treatment. Multivariate logistic
regression was used to examine factors that could affect the response
to PRGF treatment. The model contained all variables: demographic,
clinical and synovial ﬂuid angiogenic markers. The predictive values are
presented as odds ratios (OR) with 95% conﬁdence intervals (CI) and
probability values.
Results: The mean age was 65 years (range: 44−80), 54% of the
patients were females, and BMI was 28±3.5 kg/m2 (range: 22−38). The
percentage of patients who achieved >20% and >40% reduction in clinical
features according to WOMAC subscales was 19.8% and 35.8% for pain,
15.8% and 38.2% for rigidity, and 22.2% and 19.8% for function.
Baseline levels of angiogenic biomarkers were: VEGF-A: 941±483 pg/ml;
HGF: 884±589 pg/ml and TGF-b1: 860±1032 pg/ml. Correlations were
observed between TGF-b1 and VEGF (0.495, p< 0.001), TGF-b1 and
HGF (0.628, p< 0.001), and VEGF and HGF (0.469, p = 0.001). VEGF
was associated with Ahlba¨ck grade (0.295, p = 0.011). The levels of TGF-
b1 were associated with baseline rigidity and function WOMAC subscales,
Pearson coefﬁcients 0.233, p = 0.038 (rigidity) and 0.250, p = 0.030 (func-
tion). Baseline HGF was associated with function 0.287, p = 0.013.
ANCOVA analysis showed that VEGF levels, when adjusted for age, were
modiﬁed in response to PRGF treatment (p = 0.008).
After considering demographic, clinical, and biological factors in the
regression analyses, the variables signiﬁcantly involved in pain reduc-
tion were changes in VEGF during treatment (OR=1.040, CI = 1.008 to
1.072; p = 0.013) in conjunction with sex (OR=0.152, CI = 0.03 to 0.767;
p = 0.023). It is also noteworthy that we observed a weak association
of baseline TGF-b1 with pain reduction (OR=0.999, CI = 0.998 to 1.000;
p = 0.091). The variables signiﬁcantly involved in rigidity reduction (>20%)
were baseline pain (OR=0.858, CI = 0.745 to 0.988; p = 0.033) in conjunc-
tion with baseline HGF (OR=0.997, CI = 0.994 to 0.999; p = 0.010).
Conclusions: The complexity of OA requires novel approaches that iden-
tify angiogenic biomarkers and their relationship with joint homeostasis
and disease activity.
